Based on our DecisionBase 2010 report, Rheumatoid Arthritis: Opportunity Awaits Therapies That Meet Physicians’ Efficacy Expectations in TNF-α Inhibitor-Refractory Patients, Decision Resources is offering an exclusive webinar entitled Can Your Drug Gain An Edge in the TNF-Alpha Refractory Patient Segment of the Rheumatoid Arthritis Market? Exploring Drug Attributes Needed to Maximize Patient Share. Because this webinar features major report findings, it is ONLY available to purchasers of this report. This webinar was held on January 27, 2010. Contact us to learn how you can purchase this report and access a recorded playback of this event. Click here to view the invite.
Send to a Friend